Literature DB >> 1510523

Coagulation defects in neonates during cardiopulmonary bypass.

F H Kern1, N J Morana, J J Sears, P R Hickey.   

Abstract

We examined components of the coagulation system in 30 neonates (age, 1 to 30 days) undergoing deep hypothermic cardiopulmonary bypass (CPB). A coagulation profile consisting of activated clotting time; prothrombin time; partial thromboplastin time; factors II, V, VII, VIII, IX, X, and I (fibrinogen); antithrombin III; platelet count; and heparin levels was evaluated before bypass, at three intervals during bypass (1 minute after initiation of bypass, stable hypothermic CPB, warm CPB), after weaning from CPB and administration of protamine, and 2 to 3 hours after skin closure. The initiation of CPB resulted in a 50% decrease in circulating coagulation factors and antithrombin III levels. Platelet counts were reduced by 70% with CPB initiation. Neither deep hypothermic temperatures nor prolonged exposure to extracorporeal surfaces had any additional effect on the coagulation profiles. This suggests that the coagulation system of a neonate undergoing CPB is profoundly and globally effected by hemodilution. We believe that treatment of post-CPB coagulopathy in neonates must address these global deficits.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1510523     DOI: 10.1016/0003-4975(92)90451-9

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  21 in total

1.  Clinical role of blood heparin level monitoring during open heart surgery.

Authors:  T Ohata; Y Sawa; S Ohtake; M Nishimura; C J Chan; K Suzuki; H Matsuda
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1999-12

2.  Effect of tranexamic acid on blood loss in pediatric cardiac surgery: a randomized trial.

Authors:  Kazuyoshi Shimizu; Yuichiro Toda; Tatsuo Iwasaki; Mamoru Takeuchi; Hiroshi Morimatsu; Moritoki Egi; Tomohiko Suemori; Satoshi Suzuki; Kiyoshi Morita; Shunji Sano
Journal:  J Anesth       Date:  2011-09-24       Impact factor: 2.078

Review 3.  Is recombinant activated factor VII effective in the treatment of excessive bleeding after paediatric cardiac surgery?

Authors:  Kelechi E Okonta; Frank Edwin; Bode Falase
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-07-18

Review 4.  Management and monitoring of anticoagulation for children undergoing cardiopulmonary bypass in cardiac surgery.

Authors:  Colleen E Gruenwald; Cedric Manlhiot; Lynn Crawford-Lean; Celeste Foreman; Leonardo R Brandão; Brian W McCrindle; Helen Holtby; Ross Richards; Helen Moriarty; Glen Van Arsdell; Anthony K Chan
Journal:  J Extra Corpor Technol       Date:  2010-03

Review 5.  Monitoring during paediatric cardiac anaesthesia.

Authors:  J P Purday
Journal:  Can J Anaesth       Date:  1994-09       Impact factor: 5.063

6.  Pharmacokinetics of tranexamic acid in neonates and infants undergoing cardiac surgery.

Authors:  Ralph Gertler; Michael Gruber; Stanislas Grassin-Delyle; Saïk Urien; Klaus Martin; Peter Tassani-Prell; Siegmund Braun; Simon Burg; Gunther Wiesner
Journal:  Br J Clin Pharmacol       Date:  2017-03-31       Impact factor: 4.335

7.  The quantitative and qualitative responses of platelets in pediatric patients undergoing cardiopulmonary bypass surgery.

Authors:  Vera Ignjatovic; Jenny Than; Robyn Summerhayes; Fiona Newall; Steve Horton; Andrew Cochrane; Paul Monagle
Journal:  Pediatr Cardiol       Date:  2011-08-02       Impact factor: 1.655

8.  Safety of aprotinin in congenital heart operations: results from a large multicenter database.

Authors:  Sara K Pasquali; Matthew Hall; Jennifer S Li; Eric D Peterson; James Jaggers; Andrew J Lodge; Jeffrey P Jacobs; Marshall L Jacobs; Samir S Shah
Journal:  Ann Thorac Surg       Date:  2010-07       Impact factor: 4.330

Review 9.  Epsilon aminocaproic acid reduces blood transfusion and improves the coagulation test after pediatric open-heart surgery: a meta-analysis of 5 clinical trials.

Authors:  Jun Lu; Haoyu Meng; Zhaoyi Meng; Ying Sun; John P Pribis; Chunyan Zhu; Quan Li
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01

10.  Aprotinin attenuates the elevation of pulmonary vascular resistance after cardiopulmonary bypass.

Authors:  Tae-Jin Yun; Joon-Ryang Rho
Journal:  J Korean Med Sci       Date:  2006-02       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.